Cargando…

The Unrecognized Effects of Phosphodiesterase 4 on Epithelial Cells in Pulmonary Inflammation

Acute pulmonary inflammation is characterized by migration of polymorphonuclear neutrophils (PMNs) into the different compartments of the lung, passing an endothelial and epithelial barrier. Recent studies showed evidence that phosphodiesterase (PDE)4-inhibitors stabilized endothelial cells. PDE4B a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Konrad, Franziska M., Bury, Annette, Schick, Martin A., Ngamsri, Kristian-Christos, Reutershan, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409344/ https://www.ncbi.nlm.nih.gov/pubmed/25909327 http://dx.doi.org/10.1371/journal.pone.0121725

Ejemplares similares

0997. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation
por: Konrad, F, et al.
Publicado: (2014)

Inhibition of SDF-1 receptors CXCR4 and CXCR7 attenuates acute pulmonary inflammation via the adenosine A(2B)-receptor on blood cells
por: Konrad, Franziska Magdalena, et al.
Publicado: (2017)

Fractalkine Is Linked to the Necrosome Pathway in Acute Pulmonary Inflammation
por: Ngamsri, Kristian-Christos, et al.
Publicado: (2021)

Anti-inflammatory Effects of Heme Oxygenase-1 Depend on Adenosine A(2A)- and A(2B)-Receptor Signaling in Acute Pulmonary Inflammation
por: Konrad, Franziska M., et al.
Publicado: (2017)

How Adhesion Molecule Patterns Change While Neutrophils Traffic through the Lung during Inflammation
por: Konrad, Franziska M., et al.
Publicado: (2019)

0993. Heme oxygenase - 1 attenuates acute pulmonary inflammation by decreasing the release of segmented neutrophils from the bone marrow
por: Konrad, F, et al.
Publicado: (2014)

Sevoflurane Dampens Acute Pulmonary Inflammation via the Adenosine Receptor A2B and Heme Oxygenase-1
por: Ngamsri, Kristian-Christos, et al.
Publicado: (2022)

Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation
por: Ngamsri, Kristian-Christos, et al.
Publicado: (2020)

Clinical Implication of Phosphodiesterase-4-Inhibition
por: Schick, Martin Alexander, et al.
Publicado: (2022)

CXCR4 and CXCR7 Inhibition Ameliorates the Formation of Platelet–Neutrophil Complexes and Neutrophil Extracellular Traps through Adora2b Signaling
por: Ngamsri, Kristian-Christos, et al.
Publicado: (2021)

Phosphodiesterase-4 inhibition with rolipram attenuates hepatocellular injury in hyperinflammation in vivo and in vitro without influencing inflammation and HO-1 expression
por: Wollborn, Jakob, et al.
Publicado: (2015)

Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
por: Udalov, Sergey, et al.
Publicado: (2010)

Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease
por: Rhee, Chin Kook, et al.
Publicado: (2020)

Unrecognized Cystocele
Publicado: (1830)

The Unrecognized Chancre
Publicado: (1902)

Impacts of anti‐inflammatory phosphodiesterase inhibitors on a murine model of chronic pulmonary inflammation
por: Zheng, Xiao‐Fang, et al.
Publicado: (2021)

Correction to: Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
por: Udalov, Sergey, et al.
Publicado: (2022)

Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis
por: Kolb, Martin, et al.
Publicado: (2023)

Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation
por: Li, Heng, et al.
Publicado: (2021)

Grad-seq shines light on unrecognized RNA and protein complexes in the model bacterium Escherichia coli
por: Hör, Jens, et al.
Publicado: (2020)

Phosphodiesterase-4 Inhibition in Psoriasis
por: Milakovic, Milica, et al.
Publicado: (2021)

Myocardial bridge: an unrecognized cause of chest pain in pulmonary arterial hypertension
por: Rajmohan, Divya, et al.
Publicado: (2020)

Increased Levels of BAMBI Inhibit Canonical TGF-β Signaling in Chronic Wound Tissues
por: Ehnert, Sabrina, et al.
Publicado: (2023)

Pulmonary Interstitial Glycogenosis: An Unrecognized Etiology of Persistent Pulmonary Hypertension of the Newborn in Congenital Heart Disease?
por: Radman, Monique R., et al.
Publicado: (2012)

The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases
por: Butrous, Ghazwan
Publicado: (2014)

Bench-to-bedside review: Acute respiratory distress syndrome – how neutrophils migrate into the lung
por: Reutershan, Jörg, et al.
Publicado: (2004)

Unrecognized pseudohyperkalaemia in essential thrombocythaemia
por: Mannu, Gurdeep Singh, et al.
Publicado: (2011)

An Unrecognized Fracture of the Neck of the Femur
por: Wyckoff, C. C.
Publicado: (1879)

CXCR2 in Acute Lung Injury
por: Konrad, F. M., et al.
Publicado: (2012)

The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review
por: Peixoto, Christina Alves, et al.
Publicado: (2015)

Editorial: Cyclic Nucleotide Phosphodiesterases (PDEs) in Immune Regulation and Inflammation
por: Brocke, Stefan, et al.
Publicado: (2022)

Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells
por: Growcott, Ellena J, et al.
Publicado: (2006)

Bench-to-bedside review: Adenosine receptors – promising targets in acute lung injury?
por: Schepp, Carsten P, et al.
Publicado: (2008)

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020)

Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
por: Nikolova, Sevdalina, et al.
Publicado: (2010)

Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling
por: Tian, Xia, et al.
Publicado: (2011)

IgG4-related disease: a systematic review of this unrecognized disease in pediatrics
por: Karim, Faiz, et al.
Publicado: (2016)

Phosphodiesterase 4-targeted treatments for autoimmune diseases
por: Kumar, Neal, et al.
Publicado: (2013)

Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
por: Li, Heng, et al.
Publicado: (2018)

Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis
por: Janosova, Viera, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qnmu5ttcp0mibnpki7i9mnuau2